Abstract:What's new? TLR13 has a well‐established function in enhancing host defenses against pathogenic bacteria. However, its role in maintaining intestinal homeostasis and controlling colitis‐associated colon cancer is largely unknown. Using an animal model, here the authors show that Tlr13 deficiency accelerates tumorigenesis with increased production of proinflammatory cytokines and enhanced STAT3/NF‐κB/MAPK signaling. These findings point to TLR13 as a potential protective receptor for maintaining intestinal homeostasis and controlling colitis‐associated colon cancer development. The study provides novel translational insights into the prevention of colitis‐associated colon cancer by TLR13‐mediated signaling. Appropriate host‐microbiota interactions are essential for maintaining intestinal homeostasis; hence, an imbalance in these interactions leads to inflammation‐associated intestinal diseases. Toll‐like receptors (TLRs) recognize microbial ligands and play a key role in host–microbe interactions in health and disease. TLR13 has a well‐established function in enhancing host defenses against pathogenic bacteria. However, its role in maintaining intestinal homeostasis and controlling colitis‐associated colon cancer (CAC) is largely unknown. This study aimed to investigate the involvement of TLR13‐mediated signaling in intestinal homeostasis and colonic tumorigenesis using ex vivo cell and in vivo CAC animal model. Tlr13‐deficient mice were prone to dextran sodium sulfate (DSS)‐induced colitis. During the early stages of the CAC regimen (AOM/DSS‐treated), Tlr13 deficiency led to severe ulcerative colitis. Moreover, Tlr13‐deficient mice exhibited increased intestinal permeability, as evidenced by elevated levels of fluorescein isothiocyanate (FITC)‐dextran, endotoxins, and bacterial translocation. Enhanced cell survival and proliferation of colonic intestinal cells were observed in Tlr13‐deficient mice. A transcriptome analysis revealed that Tlr13 deficiency is associated with substantial changes in gene expression profile of colonic tumor tissue. Tlr13‐deficient mice were more susceptible to CAC, with increased production of interleukin (IL)‐6, IL‐12, and TNF‐α cytokines and enhanced STAT3, NF‐κB, and MAPK signaling in colon tissues. These findings suggest that TLR13 plays a protective role in maintaining intestinal homeostasis and controlling CAC. Our study provides a novel perspective on intestinal health via TLR13‐mediated signaling, which is crucial for deciphering the role of host‐microbiota interactions in health and disease.

Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer

Toll-Like Receptor 4 Signaling Integrates Intestinal Inflammation with Tumorigenesis: Lessons from the Murine Model of Colitis-Associated Cancer

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

Toll-like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer.

Toll-like receptor 3 signaling attenuated colitis-associated cancer development in mice

TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155

Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer

Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility

Expression of the Novel Adipokine C1qTNF-related Protein 4 (CTRP4) Suppresses Colitis and Colitis-Associated Colorectal Cancer in Mice

Toll‐like receptor 13‐mediated signaling protects against the development of colon cancer

Altered Gut Microbiota Promotes Colitis-Associated Cancer in IL-1 Receptor–Associated Kinase M–Deficient Mice

INNATE TL1A SIGNALING PROMOTES INTESTINAL NEUTROPHIL ACTIVATION AND COLITIS ASSOCIATED CANCER

Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis

Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer

CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice

Toll-like receptor 4 prevents AOM/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice

Amending microbiota by targeting intestinal inflammation with TNF blockade attenuates development of colorectal cancer

Mechanisms of Immune Signaling in Colitis-Associated Cancer

Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model

Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer